Our Board of Directors is the governing body of the Canadian Stem Cell Foundation. It sets the overall strategic direction and policy for the Foundation and provides financial stewardship for the organization.

Dr. Alan Bernstein, OC, PhD, FRSC, (Chair), President & CEO, Canadian Institute for Advanced Research; Founding President, Canadian Institutes of Health Research

Dr. Bernstein was the founding President of the Canadian Institutes of Health Research between 2000-2007. Following that, he went on to become the Executive Director of the Global HIV Vaccine Enterprise in New York (2008-2011). His research on cancer and stem cells was conducted first at the Ontario Cancer Institute and then at the Samuel Lunenfeld Research Institute where he served as the Director of Research from 1994-2000. Dr. Bernstein has received numerous awards and honours for his research, including the McLaughlin Medal of the Royal Society of Canada, the Genetics Society of Canada Award of Excellence and the Australian Society for Medical Research Medal. He is a Senior Fellow at Massey College, the recipient of 6 honorary degrees and the Gairdner Wightman Award and is an Officer of the Order of Canada.

Dr. Allen C. Eaves, OBC, MD, PhD, FRCPC, Founder, President & CEO, STEMCELL Technologies, Inc.

Dr. Eaves is the Founder, President & CEO of STEMCELL Technologies Inc. and its spin-off companies, Malachite Management Inc. and STEMSOFT Software Inc. He founded the Terry Fox Laboratory for Hematology/Oncology Research at the BC Cancer Agency, was Head of Clinical Hematology at the University of British Columbia and led building the Leukemia and Bone Marrow Transplant Program of BC.  Dr. Eaves has been elected President of the International Society for Cellular Therapy and the American Society of Blood and Marrow Transplantation as well as Treasurer of the Foundation for the Accreditation of Cellular Therapies. He has been Board Chair of the Mathematics of Information Technology and Complex Systems (MITACS) and is a Board Member of Mprime, the Stem Cell Network and the Centre for Commercialization of Regenerative Medicine.

Ms. Miranda Hubbs, CFA, MBA, Independent Corporate Director

Ms. Hubbs is currently a Corporate Director of Agrium Inc., the Public Sector Pension Investment Board and has previously served on the Board of Directors of Spectra Energy Corporation. She is a member of the Canadian Red Cross Board of Directors as well as a founding member and past National Co-Chair of the Canadian Red Cross Tiffany Circle – Women Leading Through Philanthropy.  Ms. Hubbs holds a BSc from Western University and an MBA from Shulich School of Business at York University.

Mr. R. Peter MacKinnon, OC, QC, LL.M, President Emeritus, Athabasca University; Retired President & Vice-Chancellor, University of Saskatchewan

Prior to his retirement as President and Vice-Chancellor of the University of Saskatchewan, Prof. MacKinnon served as Acting Vice-President (Academic), Dean of Law and Assistant, Associate and Full Professor of Law. His national appointments include the Prime Minister’s Advisory Committee on the Public Service, the Science, Technology and Innovation Council of Canada, and the Canadian Judicial Council Chairperson’s Advisory Group. Prof. MacKinnon is the recipient of many professional and service awards including the Saskatchewan Centennial Medal and the Queen Elizabeth II Diamond Jubilee Medal.

The Hon. A. Anne McLellan, OC, PC, Senior Advisor, Bennett Jones LLP; Corporate Director, Cameco Corp. and Agrium Inc.; Chancellor, Dalhousie University

Ms. McLellan works with the national law firm Bennett Jones LLP and is Distinguished Scholar in Residence at the University of Alberta in the Alberta Institute for American Studies.  She served as the Liberal Member of Parliament for Edmonton Centre from 1993 to 2006 and between 2003 and 2006 held the position of Deputy Prime Minister and Minister of Public Safety and Emergency Preparedness.  Prior to that, Ms. McLellan was Minister of Health, Minister of Justice and Attorney General, Minister of Natural Resources and Federal Interlocutor for Métis and Non-Status Indians.  Before entering politics Ms. McLellan taught law at the University of New Brunswick and the University of Alberta.

Dr. Denis Claude Roy, MD, PhD, FRCPC, CEO CellCAN Regenerative Medicine and Cell Therapy Network; Research Director, CIUSSS de l’Est-de-l’île-de-Montréal

Dr. Roy is the Director of the Cellular Therapy Laboratory and the Scientific Director of the Maisonneuve-Rosemont Hospital Research Centre as well as a full professor at the University of Montréal and an adjunct professor at McGill University. The CEO of CellCAN Regenerative Medicine and Cell Therapy Network, Dr. Roy’s research interests focus on the immunobiology of stem cell transplantation. He is particularly interested in finding ways to eliminate the risks of stem cell grafts being rejected while optimizing their anti-cancer activity.